Local and Systemic Oxidative Stress Status in Chronic Obstructive Pulmonary Disease Patients

Overview

Journal Can Respir J

Publisher Wiley

Specialty Pulmonary Medicine

Date 2013 Mar 5

PMID 23457673

Citations 27

Authors

Mian Zeng

Yue Li

Yujie Jiang

Guifang Lu

Xiaomei Huang

Kaipan Guan

Affiliations

Soon will be listed here.

Abstract

Background: Previous studies have indicated that oxidative stress plays an important role in the pathogenesis of chronic obstructive pulmonary disease (COPD).

Objectives: To study local and systemic oxidative stress status in COPD patients, and to clarify the relationship between local and systemic oxidative stress.

Methods: Lipid peroxide malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD) and GSH peroxidase (GSH-PX) levels in induced sputum and plasma, as well as glucocorticoid receptor (GR) levels in peripheral blood leukocytes were examined in 43 acute exacerbation of COPD patients (group A), 35 patients with stable COPD (group B) and 28 healthy controls (14 smokers [group C]; 14 nonsmokers [group D]).

Results: MDA levels in induced sputum and plasma decreased progressively in groups A to D, with significant differences between any two groups (P<0.001). GSH, SOD and GSH-PX levels in both induced sputum and plasma increased progressively in groups A to D, with significant differences between any two groups (P<0.001). GR levels in peripheral blood leukocytes decreased progressively in groups D to A (all comparisons P<0.001). Pearson analysis revealed strong correlations between MDA, GSH, SOD and GSH-PX levels in plasma and induced sputum. The activity of SOD in plasma and sputum were both positively correlated with GR levels (partial correlation coefficients 0.522 and 0.574, respectively [P<0.001]).

Conclusions: Oxidative stress levels were elevated in COPD patients. There was a correlation between local and systemic oxidative status in COPD, and between decreased SOD activity and decreased GR levels in COPD patients.

Citing Articles

Association between vitamin D levels and preserved ratio impaired spirometry: an investigation of mediating roles of systemic inflammation and metabolic indicators.

Lin T, Huang S, Zhou F, Shen X, Mao H Front Nutr. 2025; 12:1527333.

PMID: 39944959 PMC: 11813788. DOI: 10.3389/fnut.2025.1527333.

Oxidative Stress and Antioxidants in Pediatric Asthma's Evolution and Management.

Ioniuc I, Lupu A, Dragan F, Tarnita I, Alexoae M, Streanga V Antioxidants (Basel). 2024; 13(11).

PMID: 39594473 PMC: 11590961. DOI: 10.3390/antiox13111331.

Unveiling mechanisms of lung aging in COPD: A promising target for therapeutics development.

Devulder J Chin Med J Pulm Crit Care Med. 2024; 2(3):133-141.

PMID: 39403409 PMC: 11471098. DOI: 10.1016/j.pccm.2024.08.007.

Transcriptional Dynamics of NRF2 Overexpression and KEAP1-NRF2 Inhibitors in Human Cell Line and Primary Lung Cells.

Hamblet C, Bjorhall K, Busch S, Gehrmann U, Oberg L, Kubisch-Dohmen R Antioxidants (Basel). 2024; 13(8).

PMID: 39199170 PMC: 11351141. DOI: 10.3390/antiox13080924.

Nasal oxidative stress mediating the effects of colder temperature exposure on pediatric asthma symptoms.

He L, Norris C, Palaguachi-Lopez K, Barkjohn K, Li Z, Li F Pediatr Res. 2024; 96(4):1045-1051.

PMID: 38605092 DOI: 10.1038/s41390-024-03196-2.

References

Berry M, Hargadon B, Shelley M, Parker D, Shaw D, Green R . Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med. 2006; 354(7):697-708. DOI: 10.1056/NEJMoa050580. View

Corrigan C, Loke T . Clinical and molecular aspects of glucocorticoid resistant asthma. Ther Clin Risk Manag. 2008; 3(5):771-87. PMC: 2376076. View

Paglia D, Valentine W . Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967; 70(1):158-69. View

Brightling C, Monterio W, Green R, Parker D, Morgan M, Wardlaw A . Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir Med. 2002; 95(12):999-1002. DOI: 10.1053/rmed.2001.1195. View

Wasowicz W, Neve J, Peretz A . Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem. 1993; 39(12):2522-6. View

Zeng M, Wen Y, Liu L, Wang H, Guan K, Huang X . Role of TNF-α, sTNF-R55 and sTNF-R75 in inflammation of acute exacerbations of chronic obstructive pulmonary disease. Respiration. 2009; 78(4):399-403. DOI: 10.1159/000210263. View

Rabe K, Hurd S, Anzueto A, Barnes P, Buist S, Calverley P . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007; 176(6):532-55. DOI: 10.1164/rccm.200703-456SO. View

Marwick J, Caramori G, Stevenson C, Casolari P, Jazrawi E, Barnes P . Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice. Am J Respir Crit Care Med. 2009; 179(7):542-8. DOI: 10.1164/rccm.200810-1570OC. View

Altuntas E, Turgut T, Ilhan N, Deveci F, Muz H, Celik I . [The levels of oxidant and antioxidant in patients with COPD]. Tuberk Toraks. 2004; 51(4):373-9. View

10.

Rytila P, Rehn T, Ilumets H, Rouhos A, Sovijarvi A, Myllarniemi M . Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD. Respir Res. 2006; 7:69. PMC: 1524947. DOI: 10.1186/1465-9921-7-69. View

11.

Zeng M, Wu J, Xie C, Yan Y, Chen D, Xuan J . [Safety of sputum induction in subjects with acute exacerbations of chronic obstructive pulmonary disease]. Zhonghua Jie He He Hu Xi Za Zhi. 2005; 28(4):238-41. View

12.

Matthews J, Ito K, Barnes P, Adcock I . Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. J Allergy Clin Immunol. 2004; 113(6):1100-8. DOI: 10.1016/j.jaci.2004.03.018. View

13.

Boorsma M, Lutter R, van de Pol M, Out T, Jansen H, Jonkers R . Repeatability of inflammatory parameters in induced sputum of COPD patients. COPD. 2007; 4(4):321-9. DOI: 10.1080/15412550701597720. View

14.

Beier J, Beeh K, Kornmann O, Buhl R . Stability of glutathione in induced sputum: impact of freezing. Respiration. 2003; 70(5):523-7. DOI: 10.1159/000074211. View

15.

Harju T, Peltoniemi M, Rytila P, Soini Y, Salmenkivi K, Board P . Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients. Respir Res. 2007; 8:48. PMC: 1939846. DOI: 10.1186/1465-9921-8-48. View

16.

Grootendorst D, Sont J, Willems L, Kluin-Nelemans J, van Krieken J, Veselic-Charvat M . Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies. Clin Exp Allergy. 1997; 27(7):769-79. View

17.

Umland S, Schleimer R, Johnston S . Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma. Pulm Pharmacol Ther. 2002; 15(1):35-50. DOI: 10.1006/pupt.2001.0312. View

18.

Kinnula V, Ilumets H, Myllarniemi M, Sovijarvi A, Rytila P . 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD. Eur Respir J. 2006; 29(1):51-5. DOI: 10.1183/09031936.00023606. View

19.

Hector A, Jonas F, Kappler M, Feilcke M, Hartl D, Griese M . Novel method to process cystic fibrosis sputum for determination of oxidative state. Respiration. 2009; 80(5):393-400. DOI: 10.1159/000271607. View

20.

Loke T, Mallett K, Ratoff J, OConnor B, Ying S, Meng Q . Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patients. J Allergy Clin Immunol. 2006; 118(2):368-75. DOI: 10.1016/j.jaci.2006.04.055. View